IfPA’s Patient Access Policy Blog

Summit on Biologics and Biosimilars Tackles Choice, Switching & Patient Access

Physicians and patients are no longer asking if a biological medicine is the best choice, but – more likely – which biological medicine is the

Read More

New AfPA Video Examines “The Interchangeability Promise”

First came biologics, then biosimilars.  And soon, explains a newly released video from The Alliance for Patient Access, patients can expect interchangeable biosimilars.  According to

Read More

How to Achieve Hepatitis Elimination

Eliminating hepatitis B and C can be done, experts agree. And this week, a new report from the National Academies of Sciences, Engineering, and Medicine

Read More

Access Worries Persist after ICER’s Arthritis Report, Meeting

A drug pricing watchdog group had its final say Friday on targeted arthritis treatments – and it may not be good news for patients. The

Read More

Will Political Finger-pointing Dampen Zika Vaccine Efforts?

A vaccine for Zika virus is in the works with the potential to halt the devastating disease that’s spread to more than 5,000 people and

Read More

Can the Gas Company’s Model Help Seniors Manage Rx Co-pays?

Senior citizens can face crippling out-of-pocket costs for their Medicare Part D prescription drugs. But now the University of Pennsylvania’s Perelman School of Medicine has

Read More

Cardiac Meds Cut Patients’ Heart Attack Risk – Or Your Money Back

Cholesterol-lowering drugs known as PCSK9 inhibitors can reduce the risk of heart, stroke and cardiovascular death by 20 percent, new research confirms.  And if patients

Read More

How a Human Milk Diet Protects Premature Infants

“Breast is best” is familiar advice for new mothers and infant health care providers.  But what about mothers of preemies, who often struggle to produce

Read More

Poor & Black Children Bear the Brunt of Asthma, Research Confirms

More than 6 million children in the United States suffer from asthma. But several new studies paint a startling picture of how this disease impacts

Read More

“Death Panel” Trigger Could Limit Medicare Access

Once dubbed a “death panel”, the Independent Payment Advisory Board is back in the news. The board was devised under the Affordable Care Act as

Read More
Back to Top